Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii

Toxoplasma gondii (T. gondii) is one of the most successful parasites in the world, because about a third of the world's population is seropositive for toxoplasmosis. Treatment regimens for toxoplasmosis have remained unchanged for the past 20 years, and no new drugs have been introduced to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharibi, Zahra, Shahbazi, Behzad, Gouklani, Hamed, Nassira, Hoda, Rezaei, Zahra, Ahmadi, Khadijeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070243/
https://www.ncbi.nlm.nih.gov/pubmed/37012275
http://dx.doi.org/10.1038/s41598-023-32388-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070243/
https://www.ncbi.nlm.nih.gov/pubmed/37012275
http://dx.doi.org/10.1038/s41598-023-32388-9

Ejemplares similares